Cui et al. identified a subpopulation within selinexor-resistant cells that exhibits cancer stem cell–like properties, characterized by reduced GPX4 activity and decreased SLC7A11 expression, resulting in impaired GSH synthesis. The gene discussed is GPX4; the disease is cancer.